CDT EQUITY INC. Shareholders' Equity
CDT EQUITY INC. (CDT) had Shareholders' Equity of $103.09 million as of 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-08
- 2026-06-30: Stockholders' Equity Attributable to Parent $103.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $105.45M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$7.17M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $4.28M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $103.09M S-1 · filed 2026-09-08 | |
| 2026-03-31 | $105.45M S-1 · filed 2026-09-08 | |
| 2025-12-31 | -$7.17M S-1 · filed 2026-09-08 | |
| 2025-09-30 | $4.28M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.53M S-1 · filed 2026-09-08 | |
| 2025-03-31 | $3.08M S-1 · filed 2026-09-08 | $2.69M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$6.79M S-1 · filed 2026-09-08 | |
| 2024-09-30 | -$9.12M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$5.46M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | -$3.10M 10-Q/A · filed 2025-08-14 | |
| 2023-12-31 | -$457.00K S-1 · filed 2026-09-08 | |
| 2023-09-30 | -$1.08M 10-Q/A · filed 2023-11-21 | |
| 2023-06-30 | -$14.14M 10-Q/A · filed 2024-11-14 | -$6.07M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$12.02M 10-Q/A · filed 2024-11-14 | -$5.48M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$10.09M 10-K · filed 2025-03-28 | -$4.30M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$6.49M 10-Q/A · filed 2023-11-21 | -$3.70M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$6.14M 10-Q/A · filed 2023-11-21 | -$3.30M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$3.08M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | -$5.96M 10-K · filed 2024-04-16 | $20.62K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |